Skip to main content
MedPathMedPath Home
Clinical Trials/PER-076-05
PER-076-05
Completed
未知

Secondary Prevention of Small Subcortical Vascular Brain Attacks

FUNDACION CAYETANO HEREDIA,0 sites186 target enrollmentFebruary 7, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions-I639 Cerebral infarction, unspecifiedCerebral infarction, unspecifiedI639

Overview

Phase
未知
Intervention
Not specified
Conditions
-I639 Cerebral infarction, unspecified
Sponsor
FUNDACION CAYETANO HEREDIA,
Enrollment
186
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2006
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
FUNDACION CAYETANO HEREDIA,

Eligibility Criteria

Inclusion Criteria

  • •1\. One of the lacunary syndromes adapted by Fisher and lasting more than 24 hours.
  • •2\. Absence of signs of cortical dysfunction.
  • •3\. If the S3 is hemispherical, there should not be ipsilateral carotid stenosis\> 50%.
  • •4\. Patients with high\-risk cardioembolic sources requiring anticoagulation will not be included.
  • •5\. Evidence of: A) S3 in MRI B) Absence of cortical ACV and extensive subcortical ACV (\> 1\.5 cm), both recent and remote.

Exclusion Criteria

  • •1\- Disabling ACV.
  • •2\- Previous intracranial hemorrhage or hemorrhagic stroke.
  • •3\- Age under 40 years.
  • •4\- Patients with a high risk of bleeding.
  • •5\- Patients possibly requiring anticoagulant treatment or with other antiplatelet agents in the future.
  • •6\- Previous cortical ACV.
  • •7\- Previous ipsilateral carotid endarterectomy.
  • •8\- Alteration in renal function.
  • •9\- Intolerance or contraindication to the use of aspirin or clopidogrel.
  • •10\-A score \<24 in the Minimental of Folstein.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Prevention of one sort of cerebral vascular stroke (small subcortical strokes) in patients who already suffered one before
EUCTR2005-003242-34-ESational Institutes of Neurological Disorders: Stroke2,500
Recruiting
Not Applicable
Prevention of secondary stroke by risk factor control and medication adherenceHealth Condition 1: G968- Other specified disorders of central nervous system
CTRI/2021/10/037432Department of Health and Family Welfare
Unknown
Not Applicable
Secondary Prevention of Cerebral Infarction Epidemiological Study on Cerebral Microbleedscerebral infaction
JPRN-UMIN000001230SCIENCE Study Protocol Comittee4,000
Not yet recruiting
Not Applicable
Prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage using cilostazol administration with combination enteral and parental nutrition therapy - randomized open-labeled multi-institutional prospective studyAneurysmal subarachnoid hemorrhage
JPRN-UMIN000031246Department of Neurosurgery, Kobe University Hospital120
Completed
Not Applicable
Improving the prevention of vascular events after stroke or transient ischemic attack
ISRCTN63816609Royal Devon and Exeter Foundation Trust (UK)30